Actively Recruiting
Asciminib RMP Study
Led by Novartis Pharmaceuticals · Updated on 2026-04-20
600
Participants Needed
17
Research Sites
359 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a prospective, open-label, multi-center, non-comparative, observational study to assess safety and effectiveness of Asciminib in the real-world clinical setting in Korean Chronic myeloid leukemia (CML) patients.
CONDITIONS
Official Title
Asciminib RMP Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients diagnosed with Philadelphia chromosome-positive chronic phase Chronic Myeloid Leukemia
- Currently receiving or going to receive Asciminib treatment according to locally approved label
- Willing to provide written informed consent prior to enrollment
You will not qualify if you...
- Patients with contraindications to Asciminib according to locally approved label
- Patients receiving or planning to receive any investigational medicine during the observation period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 17 locations
1
Novartis Investigative Site
Wŏnju, Gangwon-do, South Korea, 26426
Actively Recruiting
2
Novartis Investigative Site
Anyang-si, Gyeonggi-do, South Korea, 14068
Actively Recruiting
3
Novartis Investigative Site
Bucheon-si, Gyeonggi-do, South Korea, 14584
Actively Recruiting
4
Novartis Investigative Site
Uijeongbu-si, Gyeonggi-do, South Korea, 11759
Actively Recruiting
5
Novartis Investigative Site
Gyeonggi-do, Korea, South Korea, 10408
Actively Recruiting
6
Novartis Investigative Site
Incheon, Korea, South Korea, 405 760
Actively Recruiting
7
Novartis Investigative Site
Seoul, Korea, South Korea, 02841
Actively Recruiting
8
Novartis Investigative Site
Seoul, Seoul, South Korea, 03080
Actively Recruiting
9
Novartis Investigative Site
Seoul, Seoul, South Korea, 06351
Actively Recruiting
10
Novartis Investigative Site
Seoul, Yangcheon gu, South Korea, 07985
Actively Recruiting
11
Novartis Investigative Site
Suwon, Yeongtong Gu, South Korea, 16499
Actively Recruiting
12
Novartis Investigative Site
Jeollanam, South Korea, 519763
Actively Recruiting
13
Novartis Investigative Site
Pusan, South Korea, 614 735
Actively Recruiting
14
Novartis Investigative Site
Seoul, South Korea, 03722
Actively Recruiting
15
Novartis Investigative Site
Seoul, South Korea, 05505
Actively Recruiting
16
Novartis Investigative Site
Seoul, South Korea, 06591
Actively Recruiting
17
Novartis Investigative Site
Taegu, South Korea, 41944
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here